Home Stocks Novo Integrated Sciences, Inc. Stock listing
OTC:NVOS Novo Integrated Sciences, Inc. Stock Follow Novo Integrated Sciences, Inc. into a list and get an email when it puts out news.
Share price · OTC:NVOS
$0.0022 USD +0.0013 (+144.4%)
Close on Nov 20, 2026
Past year -56.0% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range $0.0008 – $0.0022 USD Nov 20, 2026
Volume 330 shares Nov 20, 2026
Market cap $43,407 USD At the close on Nov 20, 2026 · price × 19.73M shares outstanding
52-week range $0.0001 – $0.0310 USD Lowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day $3 USD Median day 110 shares · 22 days with no trades · last 3 months, Sep 3, 2026 – Nov 20, 2026 Daily closes Last 3 months, Sep 3, 2026 – Nov 20, 2026 · OTC:NVOS · USD, adjusted for splits
Day Close Change % Open High Low Volume Fri, Nov 20 $0.0022 +0.0013 +144.4% $0.0008 $0.0022 $0.0008 330 Thu, Nov 19 $0.0009 0.0000 0.0% $0.0009 $0.0009 $0.0009 0 Wed, Nov 18 $0.0009 +0.0003 +50.0% $0.0009 $0.0009 $0.0009 100 Tue, Nov 17 $0.0006 -0.0002 -25.0% $0.0006 $0.0006 $0.0006 1,330 Mon, Nov 16 $0.0008 0.0000 0.0% $0.0008 $0.0008 $0.0008 0 Fri, Nov 13 $0.0008 +0.0002 +33.3% $0.0006 $0.0008 $0.0006 2,613 Thu, Nov 12 $0.0006 -0.0002 -25.0% $0.0006 $0.0006 $0.0006 2,669 Mon, Nov 9 $0.0008 +0.0002 +33.3% $0.0008 $0.0008 $0.0008 2,800 Fri, Nov 6 $0.0006 0.0000 0.0% $0.0006 $0.0006 $0.0006 12,571 Thu, Nov 5 $0.0006 0.0000 0.0% $0.0006 $0.0006 $0.0006 1,050 Wed, Nov 4 $0.0006 0.0000 0.0% $0.0006 $0.0006 $0.0006 3,411 Wed, Oct 28 $0.0006 0.0000 0.0% $0.0006 $0.0006 $0.0006 1,001 Tue, Oct 27 $0.0006 0.0000 0.0% $0.0006 $0.0006 $0.0006 0 Mon, Oct 26 $0.0006 0.0000 0.0% $0.0006 $0.0006 $0.0006 0 Fri, Oct 23 $0.0006 -0.0001 -14.3% $0.0006 $0.0006 $0.0006 4,651 Thu, Oct 22 $0.0007 +0.0001 +16.7% $0.0007 $0.0007 $0.0007 919 Wed, Oct 21 $0.0006 0.0000 0.0% $0.0039 $0.0039 $0.0006 2,555 Tue, Oct 20 $0.0006 -0.0014 -70.0% $0.0006 $0.0006 $0.0006 100 Mon, Oct 19 $0.0020 0.0000 0.0% $0.0020 $0.0020 $0.0020 0 Fri, Oct 16 $0.0020 0.0000 0.0% $0.0020 $0.0020 $0.0020 0 Thu, Oct 15 $0.0020 0.0000 0.0% $0.0020 $0.0020 $0.0020 0 Wed, Oct 14 $0.0020 0.0000 0.0% $0.0020 $0.0020 $0.0020 8,000 Tue, Oct 13 $0.0020 0.0000 0.0% $0.0020 $0.0020 $0.0020 0 Mon, Oct 12 $0.0020 +0.0002 +11.1% $0.0018 $0.0020 $0.0018 4,934 Fri, Oct 9 $0.0018 +0.0004 +28.6% $0.0018 $0.0018 $0.0018 110 Thu, Oct 8 $0.0014 0.0000 0.0% $0.0014 $0.0014 $0.0014 0 Wed, Oct 7 $0.0014 0.0000 0.0% $0.0014 $0.0014 $0.0014 0 Tue, Oct 6 $0.0014 -0.0002 -12.5% $0.0014 $0.0014 $0.0014 110 Mon, Oct 5 $0.0016 0.0000 0.0% $0.0016 $0.0016 $0.0016 0 Fri, Oct 2 $0.0016 +0.0010 +166.7% $0.0016 $0.0016 $0.0016 5,036 Thu, Oct 1 $0.0006 0.0000 0.0% $0.0006 $0.0006 $0.0006 259 Wed, Sep 30 $0.0006 -0.0033 -84.6% $0.0014 $0.0014 $0.0006 1,780 Tue, Sep 29 $0.0039 0.0000 0.0% $0.0039 $0.0039 $0.0039 1,000 Mon, Sep 28 $0.0039 0.0000 0.0% $0.0006 $0.0039 $0.0006 1,104 Fri, Sep 25 $0.0039 0.0000 0.0% $0.0039 $0.0039 $0.0039 0 Thu, Sep 24 $0.0039 0.0000 0.0% $0.0039 $0.0039 $0.0039 0 Wed, Sep 23 $0.0039 0.0000 0.0% $0.0039 $0.0039 $0.0039 0 Tue, Sep 22 $0.0039 0.0000 0.0% $0.0039 $0.0039 $0.0039 0 Mon, Sep 21 $0.0039 0.0000 0.0% $0.0039 $0.0039 $0.0039 5,645 Fri, Sep 18 $0.0039 0.0000 0.0% $0.0039 $0.0039 $0.0039 0 Thu, Sep 17 $0.0039 0.0000 0.0% $0.0039 $0.0039 $0.0039 0 Wed, Sep 16 $0.0039 0.0000 0.0% $0.0039 $0.0039 $0.0039 0 Tue, Sep 15 $0.0039 0.0000 0.0% $0.0039 $0.0039 $0.0039 0 Mon, Sep 14 $0.0039 0.0000 0.0% $0.0039 $0.0039 $0.0039 0 Fri, Sep 11 $0.0039 0.0000 0.0% $0.0039 $0.0039 $0.0039 500 Thu, Sep 10 $0.0039 0.0000 0.0% $0.0039 $0.0040 $0.0039 1,895 Wed, Sep 9 $0.0039 0.0000 0.0% $0.0039 $0.0039 $0.0039 0 Tue, Sep 8 $0.0039 0.0000 0.0% $0.0039 $0.0039 $0.0039 0 Fri, Sep 4 $0.0039 0.0000 0.0% $0.0009 $0.0039 $0.0009 2,372 Thu, Sep 3 $0.0039 +0.0004 +11.4% $0.0040 $0.0040 $0.0039 10,022
Splits 3 splits since 2015 · OTC:NVOS · every price before a split is adjusted for it
Day Ratio What Nov 7, 2023 1-for-10 Consolidation Feb 1, 2021 1-for-10 Consolidation May 5, 2015 1-for-20 Consolidation
Ticker OTC:NVOS
Asset type Stock
Sector Health care
Industry Health care services
Exchange OTC
Currency USD Novo Integrated Sciences, Inc. on 6ix
News releases 34 in all · newest Feb 22, 2021 · oldest 2014
Decks 1 deck · latest Sep 30, 2021 On this page Valuation price Nov 20, 2026
Enterprise value No statements on 6ix yet
P/E No statements on 6ix yet
EV/sales No statements on 6ix yet
EV/EBITDA No statements on 6ix yet
Price/book No statements on 6ix yet
Gross margin No statements on 6ix yet
Operating margin No statements on 6ix yet
Net margin No statements on 6ix yet
Debt to equity No statements on 6ix yet
Beta vs S&P 500 1.26 Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.
Company Mkt cap EV P/E EV/Sales EV/EBITDA P/B Net mgn Debt/Eq Beta Novo Integrated Sciences, Inc. · OTC:NVOS US$43,407 n/a n/a n/a n/a n/a n/a n/a 1.26 Adherium Ltd. · ASX:ADR US$1.74M US$3.78M n/a 7.0× n/a n/a n/a n/a n/a Accendra Health, Inc. · NYSE:ACH US$1.57M US$9.96M n/a 0.0× 0.1× n/a −6.7% n/a 0.51 CardioComm Solutions, Inc. · TSXV:EKG US$1.38M US$1.62M n/a 8.5× n/a n/a −194.6% n/a 0.00 Mobile-health Network Solutions · NASDAQ:MNDR US$842,830 −US$1.00M n/a −0.1× n/a 0.1× −41.2% 0.0× 0.38 Aesthetic Medical International Holdings Group Ltd. · OTC:PAIYY US$584,251 US$33.65M n/a 0.3× 3.6× n/a −7.4% n/a 0.43 ARCpoint Inc · TSXV:ARC US$463,091 US$1.90M n/a 3.1× n/a n/a −349.3% n/a 0.00 Com-Guard.com, Inc. · OTC:CGUD US$428,603 US$6.21M n/a 1,552× n/a n/a n/a n/a 0.31 FOXO Technologies Inc. · OTC:FOXO US$252,365 US$209,687 n/a 0.0× n/a 2.9× −12.3% 0.0× 1.30 CYIOS Corp. · OTC:CYIO US$182,065 US$2.21M n/a n/a n/a n/a n/a n/a -0.14 Cardiff Lexington Corporation · OTC:CDIX US$110,236 US$24.55M n/a 2.7× n/a n/a −126.4% n/a 0.74 Median of the others US$523,671 US$2.99M 2.7× 1.8× 1.5× −41.2% 0.0× 0.38
Team and board Officers Officer Role Robert Mattacchione Board Chairman & CEO Chris David Chief Operating Officer Vivek Sethi NVOS Principal Financial Officer (PFO)
Board Director Role Alex Flesias Chairman, Nominating & Corporate Governance Committee Robert Mattacchione Board Chairman & CEO Sarfaraz Ali Chairman, Compensation Committee, Audit Committee, Board of Directors
Events Quarter Results Share move Q1 2025 Dec 18, 2024 +1.6% Q3 2024 Jul 19, 2024 · After close −2.6% Q2 2024 Apr 15, 2024 · After close +32.8% Q1 2024 Jan 22, 2024 · After close −4.5% Q3 2023 Jul 17, 2023 · After close −7.2% Q2 2023 May 26, 2023 · After close −9.9% Q3 2022 Jul 14, 2022 · After close −1.9% Q2 2022 Apr 13, 2022 · After close +4.1% Q1 2022 Dec 14, 2021 −1.5% Q3 2021 Jul 14, 2021 +2.6%
All 11 quarters Quarter Results Share move Q2 2021 Apr 14, 2021 −10.0%
Open Events
Financials Annual, in USD
Income statement Line FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2017 FY2016 Revenue 13.3M 12.6M 11.7M 9.31M 7.86M 9.42M 8.89M 7.96M 7.18M 7.47M Cost of revenue 7.55M 7.62M 6.94M 5.48M 4.80M 5.90M 5.47M 4.99M 4.67M 4.76M Gross profit 5.74M 4.95M 4.80M 3.82M 3.06M 3.52M 3.42M 2.98M 2.51M 2.71M Research and development 0 0 0 Selling, general and administrative 14.0M 13.5M 14.4M 8.09M 7.29M 4.02M 4.88M 3.03M 2.39M 2.93M Operating income -8.31M -8.55M -25.0M -4.27M -4.26M -785.6K -1.57M -164.9K 122.0K -401.6K Depreciation and amortization 2.26M 2.30M 3.02M 1.72M 1.45M 97.1K 73.4K 67.8K 72.6K 1.01K EBITDA -6.05M -6.25M -22.0M -2.55M -2.82M -688.5K -1.50M -97.1K 194.5K -400.6K Interest expense 652.4K 5.12M 1.59M 165.0K 156.7K 222.2K 564.5K 554.7K 0 523.3K Income before tax -16.1M -13.3M -33.1M -4.47M -4.92M -403.6K -2.12M -164.9K -346.2K -2.77M Income tax -22.3K 22.3K 178.1K -46.4K 282.6K 7.52K 111.7K 0 2.40M Net income -16.1M -13.2M -33.0M -4.46M -4.92M -392.0K -2.11M -164.9K -340.5K -2.77M Earnings per share, basic -0.89 -1.30 -1.13 -1.80 -2.13 -0.18 -1.02 -0.09 -13.29
Balance sheet Line FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2017 FY2016 Cash and equivalents 844.6K 416.3K 12.7M 8.29M 2.07M 2.08M 675.7K 1.90M 110.3K 14.1K Short-term investments 0 0 0 Receivables 3.15M 1.47M 6.38M 2.28M 2.04M 1.76M 1.73M 1.50M 2.31M 1.19M Inventory 1.00M 1.11M 645.1K 339.4K 1 57.4K -785.8K 1 Current assets 5.41M 4.39M 20.1M 11.1M 4.29M 4.10M 2.57M 3.65M 2.57M 14.1K Property, plant and equipment 8.61M 3.16M 3.41M 400.3K 303.0K 318.7K 318.7K Goodwill 6.55M 7.58M 11.4M 9.49M 636.9K 623.1K 604.1K 399.4K 0 Total assets 32.1M 35.6M 71.8M 62.0M 35.4M 32.3M 4.74M 5.51M 2.89M 27.9K Accounts payable 3.24M 3.51M 1.62M 1.45M 883.8K 1.14M 1.31M 1.70M 4.94M 13.1K Current liabilities 14.6M 7.90M 12.7M 8.46M 2.60M 3.03M 3.35M 4.27M 9.97M 13.1K Long-term debt 65.0K 1.11M 6.12M 952.1K 1.20M 1.22M 5.53M 11.6K 11.6K Total debt 4.71M 4.47M 19.8M 13.7M 4.39M 5.13M 1.61M 5.54M 6.33M Total liabilities 17.5M 11.1M 27.4M 18.2M 5.82M 6.73M 4.57M 9.80M 9.97M 13.1K Shareholders' equity 14.9M 24.8M 44.4M 43.9M 29.6M 25.6M 201.4K -4.27M -7.08M 14.8K Shares outstanding 18.0M 10.2M 29.1M 2.48M 2.30M 2.17M 2.08M 1.78M 208.5K
Cash flow Line FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2017 FY2016 Cash from operations -2.24M -2.24M -5.88M -1.02M -441.7K -822.3K -934.5K -810.7K 101.4K -175.6K Capital spending -49.2K -49.2K -190.2K -255.9K -12.1K -107.6K -178.6K -38.2K -55.0K -113.9K Free cash flow -2.29M -2.29M -6.07M -1.28M -453.8K -929.9K -1.11M -848.9K 46.4K -289.5K Cash from investing -49.2K -49.2K 3.00M 657.1K -842.9K -217.2K -749.5K -462.3K -113.9K Cash from financing 763.9K 763.9K -427.1K 4.32M -271.7K 3.07M -11.6K 3.11M 402.2K 187.9K Dividends paid 0 0 0 Share buybacks 0 -62.5K 150.0K 150.0K Change in cash -1.76M -1.76M -6.11M 6.23M -15.9K 1.41M -1.22M 1.79M 42.2K 12.3K
Open Financials
Cap table Built by 6ix from Novo Integrated Sciences, Inc.’s releases
Common shares 19,730,247
Fully diluted 19,730,247 Fully diluted Line Shares Common shares 19,730,247
Share count over time Count Shares Nov 22, 2026 19,730,247
Open Cap table
People 6ix reads each seat by machine from the page it links to, and can misread one.
Person Seat Michael Pope Director · Feb 19, 2021 – Feb 23, 2022 · Past Alex Flesias Director · Feb 19, 2021 – Feb 19, 2021 · Past Alex Flesias Chairman, Nominating & Corporate Governance Committee · Since at least Nov 4, 2026 Chris David Chief Operating Officer · Since at least Nov 4, 2026 Michael Joseph Gaynor Director · Feb 19, 2021 – Feb 19, 2021 · Past Pierre Joseph Dalcourt Director · Feb 19, 2021 – Feb 19, 2021 · Past Robert Letterio Oliva Director · Feb 19, 2021 – Apr 19, 2022 · Past Robert Mattacchione Board Chairman & CEO · Since at least Feb 19, 2021 Sarfaraz Ali Chairman, Compensation Committee, Audit Committee, Board of Directors · Since at least Nov 5, 2026 Sterling M Jimenez Principal Financial Officer · Apr 20, 2021 – Apr 20, 2021 · Past
All 12 people Person Seat Thomas Edward Bray Principal Financial Officer · Feb 19, 2021 – Feb 19, 2021 · Past Vivek Sethi NVOS Principal Financial Officer (PFO) · Since at least Nov 5, 2026
Open People
Log in to ask 6ix AI your own questions about Novo Integrated Sciences, Inc.